Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 132.4 | 50.5 | 19.7 | 13.0 | 4.5 | 29.5 |
| Revenue growth | 162.3% | 156.4% | 51.6% | 189.3% | -84.8% | |
| Cost of goods sold | 0.0 | 0.0 | 1.9 | 1.2 | 0.4 | 14.8 |
| Gross profit | 132.4 | 50.5 | 17.8 | 11.8 | 4.1 | 14.8 |
| Gross margin | 100.0% | 100.0% | 90.2% | 90.9% | 90.8% | 50.0% |
| Research and development | 47.8 | 34.0 | 43.2 | 15.8 | 14.8 | 9.8 |
| General and administrative | 31.1 | 16.1 | 10.5 | 6.9 | 6.8 | 4.9 |
| EBIT | -78.9 | -50.1 | -35.9 | -10.8 | -17.6 | -14.8 |
| EBIT margin | -59.6% | -99.2% | -182.5% | -83.5% | -391.0% | -50.0% |
| Pre-tax income | -135.6 | -51.9 | -36.8 | -11.2 | -16.0 | -14.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -135.6 | -51.9 | -36.8 | -11.2 | -16.0 | -14.8 |
| Net margin | -102.4% | -102.8% | -186.9% | -85.9% | -357.2% | -50.0% |
| |
| Diluted EPS | ($6.04) | ($2.71) | ($7.47) | ($7.98) | ($11.64) | ($10.85) |
| Shares outstanding (diluted) | 22.5 | 19.2 | 4.9 | 1.4 | 1.4 | 1.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|